A controlled trial of narrowband ultraviolet B phototherapy for the treatment of uremic pruritus.

Keywords : ['narrowband ultraviolet b phototherapy', 'uremic pruritus', 'control trial', 'treatment']
Author : PB Sherjeena
22

A controlled trial of narrowband ultraviolet B phototherapy for the treatment of uremic pruritus.

Keywords : ['narrowband ultraviolet b phototherapy', 'uremic pruritus', 'control trial', 'treatment']
Author : PB Sherjeena
22

Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients - A multicenter randomized controlled study.

Keywords : ['multicenter randomize control study', 'life among hemodialysis patient', 'pharmaceutical care', 'healthrelated quality', 'impact']
Author : UV Mateti
22

Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients - A multicenter randomized controlled study.

Keywords : ['multicenter randomize control study', 'life among hemodialysis patient', 'pharmaceutical care', 'healthrelated quality', 'impact']
Author : UV Mateti
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22